跳至主要内容
临床试验/CTRI/2024/05/066758
CTRI/2024/05/066758尚未招募2 期

Efficacy and safety of Itrifal Shahtara and Marham Daad with Comparison of Majoon Ushba and Marham Raal in the management of Quba (Tinea Corporis) An Open-Labeled Randomized Comparative Clinical Study.

Government Tibbi College and Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年5月20日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Total Sign and symptom score(TSSS)

研究概览

简要总结

Patient of tinea corporis is included in the study on the basis of inclusion and exclusion criteria and the effect of unani formulation compared with standard drug

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients those who have subjective and objective signs and symptoms or diagnosed case of Tinea corporis.
  • 2.Patients with positive mycology test(KOH positive).
  • 3.Patients of either gender.
  • 4.Patients in the age group of 18-50 years.
  • 5.Patients who have agreed to participate and sign the informed consent form and follow the protocol.

排除标准

  • 1.Co-morbid conditions of the participant like DM, HTN, CAD, CKD and other autoimmune diseases.
  • 2.Participants suffering from concomitant diseases like Psoriasis and eczema.
  • 3.Pregnant or lactating women.
  • 4.Known cases of immuno-compromised states like AIDS, Malignancies and on immuno-suppressive drugs 5.Participants fail to attend treatment schedule regularly.

结局指标

主要结局

Total Sign and symptom score(TSSS)

时间窗: 1st week to 6 weeks

次要结局

  • Conversion to Negative mycology test(At 6 Week)

研究者

发起方
Government Tibbi College and Hospital
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Md Shamim Akram

Government Tibbi College and Hospital

研究点 (1)

Loading locations...

相似试验